|
Levulan Photodynamic Therapy (PDT) is
a combination of a topical photosensitizer and a special light
source which destroys targeted cells. PDT was initially used
to treat cancer cells and is now being used in the treatment
of non-cancerous conditions such as acne and for facial rejuvenation.
When used for these conditions, the photosensitizer is applied
to the face and then the skin is exposed to a light source.
Rapidly growing cells, oil glands, and other structures in
the skin absorb the photosensitizer and are destroyed by a
reaction caused by the light.
What is Photodynamic Therapy (PDT)?
When a laser is used upon the skin there are three possible
effects that can occur. One of these, photochemical, which
draws from photosensitive reactions, serves as the foundation
for photodynamic therapy (PDT).
The general idea to PDT is that certain molecules are activated
when exposed to specific wavelengths of light, if these molecules
are distributed to certain tissues in the body and then exposed
to different wavelengths of light the molecules will produce
a reaction inside the tissue. The reaction destroys the unwanted
tissue while leaving the surrounding tissue intact. In PDT
the most common photosensitizer (light-reactant chemical)
is topical aminolevulinic acid HCI (ALA), known as Levulan.
There are three different light sources that can be used in
PDT, these are: blue light (BLU-U) and intense
pulsed light (IPL).
A. Blue Light – The blue
light photodynamic therapy illuminator is designed to send
a steady flow of blue light on the skin for a thousand seconds,
this light is used to activate the light-reactant chemical
placed upon the skin. Exposure limits have been placed by
the American Nationals Standards Institute (ANSI) to protect
the skin from consequences caused by excessive exposure.
B. Intense
Pulsed Light – Because of the nature in which IPL
is used, it can be applied to the skin with less side effects
and patient downtime. When used in photorejuvenation IPL produced
excellent cosmetic results without pigment alterations or
scarring.
PDT Uses
Acne - Patients who were treated
with PDT also showed improvement in acne and a decrease in
P acnes. Clinical improvements were seen up to six months
after a single treatment of topical ALA on facial acne with
exposure to a light source four hours later. When PDT is used
to treat acne the topical ALA is applied broadly and evenly
to the affected areas—unlike AK where the topical ALA
is applied spot treatment style—and the patients are
then exposed to the light source for a thousand seconds. During
PDT on acne, patients commonly experience severe burning and
pain; however, there are many treatment methods to help acne
patients deal with the pain associated with the photodynamic
therapy, these include, but are not limited to: pretreatment
with topical anesthetics, cool compresses during therapy,
systemic steroids, non-steroidal anti-inflammatory drugs,
and even narcotics.
Actinic Keratosis - PDT is used
commonly to treat actinic keratosis (AK) which are common
lesions found most typically in lightly pigmented individuals,
and since a large number of cancerous cells begin as AK, detection
and treatment is critical. Pulse dye lasers (PDL) and intense
pulse light (IPL) devices are used to treat AK easier, faster,
and with less pain than the original blue light. Topical ALA
is applied to the individual lesions and left for thirty to
sixty minutes before being treated with IPL. The treatment
is fast and virtually pain free.
Photorejuvenation – Visible
skin damage can be distinguished by wrinkling, coarse skin
texture, pigmentation alterations, and telangectasias. Photorejuvenation
therapy with Levulan has been found to help improve and reduce
each of the different characteristics of damaged skin, including:
decreasing thickening and crusting of the skin, minimizing
pore size, improving the texture of the skin, and subtle improvement
in wrinkles.
Photodynamic Therapy Treatment
Before taking topical ALA (the medicine used during PDT) you
should tell you health care provider if you have ever had
porphyria or an allergic reaction to any medicine. Also, females
who are pregnant or plan to become pregnant should notify
their health care provider. You should not breast-feed while
taking this medicine without your health care provider’s
approval. After the physician has applied the medicine to
your sores and before the treatment your skin will be sensitive
to sunlight and bright indoor light. Shade the treated sores
if you must be outside, sunscreens will not protect your skin
after use of topical ALA. Continue to keep out of light for
24 hours after your treatment.
Side effects that can occur from photodynamic therapy treatment
include: severe stinging or burning, scaling, crusting, itching,
light or dark spots on the skin, wearing away of the skin,
puss filled pimples, mild swelling for three to five days,
and skin ulcers. These side effects are temporary and should
be gone within four weeks after the treatment. After eight
weeks your doctor will examine your sores and any that have
not healed may be treated again. The number of treatments
you need will depend on how your sores heal.
Will I feel any discomfort during the treatment with the Levulan®
PDT system?
Probably. Although the Levulan®
PDT system has been designed for less patient discomfort,
many patients do report some:
• Stinging and burning
• Swelling and temporary reddening
This discomfort usually occurs immediately following treatment,
rather than in the weeks following. Any swelling and redness
will begin to subside soon after treatment and will be gone
in a few weeks. In fact, some patients have reported that
swelling is reduced even sooner.
How many PDT sessions will I
need?
The number of photodynamic therapy treatments that have been
used has ranged from one to three (over a period of three
months).
How long after a PDT before I can return
to normal activities?
This treatment will make you extremely photosensitive and
you will be required to avoid sun exposure for 24 hours after
photosensitizer has been applied.
LEVULAN PDT
CONSENT FORM
|